Podiatrists in El Centro, CA Accepting Medicare
6 Podiatrists found. Showing 1 - 6
 Norman H. Reeves,dpm Podiatry Corp Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1530 S Imperial Ave, El Centro, CA 92243 Phone: 760-337-9113 Fax: 760-337-9108 |
Federico R Hernandez Dpm A Professional Corp Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1665 S Imperial Ave, Suite A, El Centro, CA 92243 Phone: 760-352-6062 Fax: 760-332-0400 |
Imperial Valley Podiatry Associates Inc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1503 N Imperial Ave, Suite 105, El Centro, CA 92243 Phone: 760-337-2800 Fax: 760-337-9099 |
 Dr. Cyril Methodias Gostich, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: May Accept Medicare Assignments Practice Location: 852 E Danenberg Dr, El Centro, CA 92243 Phone: 760-352-2257 Fax: 760-352-4579 |
Dr. Nicholas M Carovich, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1503 N Imperial Ave, Suite 105, El Centro, CA 92243 Phone: 760-337-2800 Fax: 760-337-9099 |
Central California Leg, Foot, And Ankle Center, Inc. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1073 Ross Ave Ste D, El Centro, CA 92243 Phone: 305-310-8155 |
News Archive
Heart pumps linked to complications in some patients who underwent stent procedures
In critically ill patients who require a heart pump to support blood circulation as part of stent procedures, specific heart pumps have been associated with serious complications, according to a new study led by cardiologists at Washington University School of Medicine in St. Louis.
Study on Drosophila flies may help develop treatments for serious human diseases: Article
A Science article published on July 9, 2010, describes the discovery of an alternative form of evolution that helps Drosophila flies conquer nematodes that sterilize them. Nematodes are among the most abundant, diverse and destructive parasites of plants and animals.
FDA issues Complete Response Letter for Horizant in treatment of RLS
GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).
Decoding funny faces to detect disease
Like Russell Crowe's character in A Beautiful Mind, life is often difficult for the 2.4 million Americans with schizophrenia.
› Verified 8 days ago
Physical Therapists
Optometrists
Occupational Therapists
Chiropractors
Podiatrists
Speech-Language Pathologists
Audiologists